After a long time, new treatment options are becoming available for patients with atopic dermatitis.There is a current need to assess which patients and sub-groups of patients are being sub-optimally treated with current options
Due to the rapidly changing landscape of the COVID-19 space, evidence generation activities must focus on data sources which contains the most up-do-date data.To support a COVID-19 therapeutic, there is a need to identify data sources which would allow timely access and analysis of data
A number of new treatment options have become available for relapse remitting multiple myeloma.Currently unknown how new treatment options are being utilised in the real world amongst patients.
© 2023 KVM Analytics. All rights reserved